Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
https://www.zacks.com/stock/news/2240974/biotech-stock-roundup-amlx-acad-down-on-study-data-mrna-rgls-gain-on-updates-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2240974
Mar 14, 2024 - Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.
0
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
https://www.zacks.com/stock/news/2268837/watch-these-5-drug-stocks-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2268837
May 06, 2024 - Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
0
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates
https://www.zacks.com/stock/news/2270022/ligand-pharmaceuticals-lgnd-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270022
May 07, 2024 - Ligand (LGND) delivered earnings and revenue surprises of 6.19% and 4.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
https://www.zacks.com/stock/news/2270880/acadia-pharmaceuticals-acad-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270880
May 08, 2024 - Acadia (ACAD) delivered earnings and revenue surprises of 150% and 0.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Pages: 1
Page 1